Artificial intelligence has become one of the most exciting areas of healthcare innovation. From clinical documentation and diagnostics to patient engagement and remote monitoring, founders are finding new ways to bring AI into almost every part of the healthcare journey.
But for healthtech startups in Southeast Asia, having an impressive AI model may not be enough to build a successful company.
The harder and ultimately more valuable challenge is making technology work within real healthcare environments.
Healthcare is not simply a collection of datasets waiting for better algorithms. It is a complex network of patients, clinicians, hospitals, laboratories, pharmacies, insurers, medical devices, regulations, and existing software systems.
The startups that understand these connections may have a much better chance of moving from an interesting pilot to a product that healthcare organisations actually use.
The opportunity is real, but so is the complexity
Southeast Asia provides significant opportunities for digital health innovation.
Across the region, healthcare systems face growing demand, ageing populations, chronic disease burdens, uneven access to specialists, and differences between urban and rural healthcare.
Digital health can help address some of these challenges.
Telehealth can extend access beyond major cities. Remote monitoring can help clinicians follow patients outside hospitals. AI can support increasingly data-intensive clinical and operational work. Digital platforms can also make parts of the patient journey easier to navigate.
Yet Southeast Asia should not be treated as one homogeneous healthcare market.
Singapore, Indonesia, Malaysia, Vietnam, Thailand, and other regional markets differ in healthcare infrastructure, regulations, digital maturity, reimbursement models, and patient behaviour.
This means a healthtech product that succeeds in one market cannot always be introduced into another with only minor changes.
For founders, localisation needs to go much deeper than translating an interface.
The real problem may be workflow, not technology
Imagine an AI system that can identify a clinically relevant pattern in patient information.
Its accuracy may be impressive.
But what happens next?
Can the system access the right information from the hospital’s existing software? Does the result appear where a clinician already works? Can the clinician review or override the recommendation? Is the decision recorded properly? Can that information move to another system without being entered manually again?
Also Read: Vietnam’s healthtech boom has a talent problem nobody is talking about
If the answers are no, a sophisticated AI model can still become another disconnected tool.
This is why workflow integration deserves much more attention from healthtech founders.
Clinicians already work under considerable time pressure. Technology that adds another login, dashboard, or manual process may technically solve one problem while creating another operational burden.
Effective healthcare technology should fit naturally into how care is delivered.
That requires founders to understand the environment surrounding their product, not only the feature they are building.
Interoperability is becoming a product issue
For years, interoperability could largely be treated as an enterprise IT concern.
That distinction is becoming harder to maintain.
A digital health product may need to exchange information with electronic health records, laboratory systems, pharmacy platforms, medical devices, payer systems, or other healthcare applications.
When these systems cannot communicate effectively, the consequences become visible at the product level.
Users re-enter information. Clinicians switch between applications. Patient records become fragmented. Automation stops halfway through a workflow.
For a startup, interoperability therefore affects usability, adoption, and scalability.
Standards-based approaches can help, but supporting a technical standard is only part of the answer. Founders also need to understand how information moves through real healthcare processes and where their product belongs within those processes.
The question should shift from “Can our platform connect to another system?” to “Can information move through this care journey without unnecessary friction?”
AI needs healthcare context
The rapid improvement of generative AI has lowered the barrier to creating healthcare prototypes.
Building a demonstration is increasingly easy.
Building a dependable healthcare product remains difficult.
Healthcare AI operates in a field where incomplete context, inconsistent data, and inaccurate outputs can have consequences far beyond a poor user experience.
That makes human oversight especially important.
Rather than trying to remove healthcare professionals from the process, startups can design AI around them.
Also Read: Healthtech in South and Southeast Asia – Seeing beyond the “obvious”
A clinical documentation tool, for example, can prepare information for professional review instead of automatically treating generated content as final. A decision-support system can surface relevant information while leaving clinical judgement with the professional responsible for the patient.
This approach may appear less dramatic than the idea of autonomous healthcare, but it can create something much more valuable: trust.
Trust is also one of the hardest things for a young healthcare company to earn.
Infrastructure will separate pilots from scalable products
Many healthtech companies begin with a narrow use case, and that is often sensible.
Problems emerge when the underlying product is built only for that first use case.
A startup might initially serve one clinic, one hospital department, or one type of patient. Growth can later require supporting multiple organisations, new integrations, larger datasets, and different regulatory environments.
Architecture decisions made early can suddenly become business constraints.
This does not mean every startup needs enterprise-scale infrastructure from day one. Overengineering can be as damaging as underengineering.
Instead, founders should understand which technical decisions will be difficult to reverse.
Data architecture, security, interoperability, auditability, and the separation of core product capabilities from market-specific requirements deserve early consideration.
Scalability is not simply about handling more users. In healthcare, it also means handling greater organisational, technical, and clinical complexity.
The strongest healthtech founders will think beyond the feature
Southeast Asia does not lack healthcare problems worth solving, and it certainly does not lack entrepreneurial ambition.
The next phase of healthtech innovation, however, may reward companies that look beyond individual features.
Instead of asking only whether AI can perform a task, founders can ask whether that capability improves an actual healthcare workflow.
Instead of viewing integration as something to address after gaining customers, they can consider how the product will coexist with the systems healthcare organisations already depend on.
Instead of treating compliance, security, and governance as barriers to innovation, they can use them as foundations for building trust.
Instead of designing a product for an abstract Southeast Asian market, they can recognise that healthcare remains deeply local.
AI will undoubtedly influence the region’s healthcare future.
But the most successful companies may not be the ones with the most impressive AI demonstrations.
They may be the ones that solve the harder problem: making technology genuinely work within healthcare.
—
Editor’s note: e27 aims to foster thought leadership by publishing views from the community. You can also share your perspective by submitting an article, video, podcast, or infographic.
The views expressed in this article are those of the author and do not necessarily reflect the official policy or position of e27.
Join us on WhatsApp, Instagram, Facebook, X, and LinkedIn to stay connected.
The post Why Southeast Asia’s next healthtech winners will be built around healthcare workflows, not just AI appeared first on e27.